Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Orlistat (Standard)
Cat. No.:
OB0425LY-257
Appearance:
Solid
Purity:
99.95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Orlistat (Standard) is an intestinal lipase inhibitor that blocks fat absorption.
Synonyms:
Orlistat; 96829-58-2; Tetrahydrolipstatin; Xenical; Orlipastat; (2S)-1-[(2S,3S)-3-Hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate; L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester; N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;
CAS No.:
96829-58-2
Compound CID:
3034010
Formula:
C29H53NO5
Formula Weight:
495.73
Specification
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Orlistat (Standard) is primarily used in obesity research to reduce body weight and improve metabolic symptoms associated with obesity.
